Figure 5.
Neurocognitive treatment-emergent adverse events (TEAEs) in patients with two consecutive LDL cholesterol levels <25 mg/dL (<0.65 mmol/L). Neurocognitive TEAEs categorized using the Sponsor custom MedDRA query. Values on chart are n (%).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.